Amadeus Capital Partners has been investing in technology-enabled products and services for over 20 years. Founded by Anne Glover and Hermann Hauser in 1997, Amadeus has backed more than 165 companies and raised over $1 billion for investment.
Our team of 30 operates from Bogotá, San Francisco, and London and Cambridge in the UK.
Pioneering businesses we’ve backed include gene-sequencing innovators Solexa, cyber security vendor ForeScout, eye-tracking specialist Tobii, Optos, a producer of advanced retinal imaging, and Kreditech, a provider of financial products to the ‘underbanked’.
Early stage investments we’ve made include Ori Biotech, a cell and gene therapy (CGT) manufacturing company, massively parallel simulation platform Improbable.io, Graphcore, innovators in intelligent microprocessors, and speech recognition company VocalIQ.
We focus on early stage, primary and secondary growth capital and emerging markets.
Investor Relations Manager
Please contact Saket Narula to enquire about investing in Amadeus Capital Partners’ funds and co-investing with us. Current investors can also access the Investor Portal.
Video: 26th November 2020
Press Release: 18th November 2020